A minimally invasive treatment known as transcatheter arterialization can help limit the risk of above-ankle amputation among patients with chronic limb-threatening ischemia (CLTI), according to new findings published in the New…

The U.S. Food and Drug Administration (FDA) has announced that Ascend Laboratories is recalling multiple lots of a direct oral anticoagulant, dabigatran etexilate. The recall is due to unacceptable…

Women with peripheral artery disease (PAD) are underdiagnosed and have worse clinical outcomes compared with men, according to a…

Shockwave Medical, the Santa Clara, California-based healthcare technology company known for developing intravascular lithotripsy (IVL) technology, has launched a new IVL catheter in the United States.

…

COVID-19 patients who were hospitalized, but not yet requiring intensive care, showed a 30% reduction in the risk of death within 30 days when given a treatment-strength dose of blood thinners compared…

The Society for Cardiovascular Angiography and Interventions (SCAI) and Association of Black Cardiologists (ABC) have sent a new letter to the Centers for Medicare…

The U.S. Food and Drug Administration (FDA) was as busy as ever in February. The agency…

Erythritol, a common artificial sweetener, is associated with a heightened risk of heart attack and stroke, according to new findings published in Nature Medicine.[1]

The study, led by a team…

The routine use of intravascular imaging (IVI) for guiding percutaneous coronary intervention (PCI) procedures is highly recommended, according to a new guidance from the American College of Cardiology (…

Complex coronary artery disease (CAD) appears to be a have a more negative impact on transcatheter aortic valve replacement (TAVR) outcomes…

Leading researchers, physicians and other specialists from all over the world gathered in Dallas on Feb. 8-10 for International Stroke Conference (…

Abbott has entered into a definitive agreement to acquire Cardiovascular Systems Inc. (CSI), a Minnesota-based healthcare technology company focused on treating peripheral artery disease (PAD) and coronary artery disease (CAD). The…

Transcatheter aortic valve replacement (TAVR) patients presenting with…

Researchers think they have identified genes responsible for the development of coronary artery disease (CAD), sharing their findings in Circulation Research, a publication of the American…

When the Society for Cardiovascular Angiography and Interventions (SCAI) issued a…

Comprehensive stroke centers (CSCs) are associated with higher in-hospital stroke rates after transcatheter aortic valve replacement (TAVR)…

More high-risk patients with pulmonary embolism (PE) should be considered for surgery, according to a new scientific statement presented Monday, Jan. 23, at the…

Using coronary CT angiography (CCTA) to evaluate coronary artery disease (CAD) is associated with lower hospitalization and mortality rates…

Two recently developed risk scores can identify bleeding risks among high-risk percutaneous coronary intervention (PCI) patients, according to new findings published in the American Journal of Cardiology.[1] These scores…

Clopidogrel monotherapy after just one month of dual-antiplatelet therapy (DAPT) may help reduce the risk of major bleeding events when diabetic patients undergo percutaneous coronary intervention (PCI), according to a new study…